HDAC9 and Friedreich ataxia: We have shown that prolonged treatment with each of the three HDAC inhibitors, 106, 136 and 109 can ameliorate FRDA disease-like effects to some extent, and therefore our studies are supportive of advancing HDAC inhibitors for treating FRDA.